Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

[1] Fagotti A(2010)Peritoneal carcinosis of ovarian origin World J Gastrointest Oncol 2 102-108

[2] Gallotta V(1993)Peritoneal metastases in pancreatic carcinoma Hepatogastroenterology 40 430-432

[3] Romano F(1979)The clinical correlation of an autopsy study of recurrent colorectal cancer Ann Surg 189 496-502

[4] del Castillo CF(2000)Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358-363

[5] Warshaw L(2016)Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives Curr Oncol 23 e266-e275-168

[6] Welch JP(1996)Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy Cancer Treat Res 81 149-51

[7] Donaldson GA(2007)Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis Recent Results Cancer Res 169 39-76

[8] Sadeghi B(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7 69-3148

[9] Arvieux C(2013)Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (hipec) Eur J Cancer 49 3140-294

[10] Glehen O(2014)Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii1iii9-42

[1] Fagotti A(2010)Peritoneal carcinosis of ovarian origin World J Gastrointest Oncol 2 102-108

[2] Gallotta V(1993)Peritoneal metastases in pancreatic carcinoma Hepatogastroenterology 40 430-432

[3] Romano F(1979)The clinical correlation of an autopsy study of recurrent colorectal cancer Ann Surg 189 496-502

[4] del Castillo CF(2000)Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358-363

[5] Warshaw L(2016)Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives Curr Oncol 23 e266-e275-168

[6] Welch JP(1996)Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy Cancer Treat Res 81 149-51

[7] Donaldson GA(2007)Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis Recent Results Cancer Res 169 39-76

[8] Sadeghi B(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7 69-3148

[9] Arvieux C(2013)Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (hipec) Eur J Cancer 49 3140-294

[10] Glehen O(2014)Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii1iii9-42